BALFX
Price
$40.37
Change
+$0.07 (+0.17%)
Updated
Jul 31 closing price
Net Assets
288.09B
MBACX
Price
$33.00
Change
+$0.05 (+0.15%)
Updated
Jul 31 closing price
Net Assets
448.9M
Interact to see
Advertisement

BALFX vs MBACX

BALFX vs MBACX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. MBACX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and MBACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 288B vs. MBACX (449M). BALFX pays higher dividends than MBACX: BALFX (1.78) vs MBACX (0.90). BALFX was incepted earlier than MBACX: BALFX (25 years) vs MBACX (24 years). MBACX (2.18) is less costly to investors than BALFX (0.61). MBACX is a more actively managed with annual turnover of: 201.00 vs. BALFX (50.00). BALFX has a lower initial minimum investment than MBACX: BALFX (250) vs MBACX (1000). BALFX annual gain was more profitable for investors over the last year : 11.29 vs. MBACX (8.32). BALFX return over 5 years is better than : 32.23 vs. MBACX (-4.65).
BALFXMBACXBALFX / MBACX
Total Expense Ratio0.612.0829%
Annual Report Gross Expense Ratio0.612.1828%
Fund Existence25 years24 years-
Gain YTD8.3727.069118%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B449M64,143%
Annual Yield % from dividends1.780.90198%
Returns for 1 year11.298.32136%
Returns for 3 years38.4917.94215%
Returns for 5 years32.23-4.65-693%
Returns for 10 years82.2411.45718%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURX0.210.01
+7.32%
Curanex Pharmaceuticals Inc.
UFI6.400.26
+4.23%
UNIFI
MNTN9.22-0.01
-0.11%
MNTN Inc.
BRO70.40-0.47
-0.66%
Brown & Brown
TOWN37.91-0.30
-0.79%
TowneBank